PHN is operationally defined as pain that persists ... Immunocompromised patients might require longer periods of treatment. Treatment should be discontinued if both VZV DNA and anti-VZV antibody ...
GTX-104 is a clinical stage, novel, injectable formulation of nimodipine being developed for intravenous (IV) infusion in aSAH patients to address significant unmet medical needs. The unique ...
Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of nimodipine ...
The final diagnoses of the patients with normal TABs were polymyalgia rheumatica (two patients), prostate carcinoma, headache with postherpetic neuralgia ... indicating that glucocorticoid treatment ...
Expert Rev Vaccines. 2010;9(3s):21-26. While there is still no standard definition for PHN, for the purposes of this review it is defined as: clinically significant pain or painful abnormal ...
Pheon's lead ADC PHN-010 is directed at a novel, undisclosed cancer antigen that it says is highly expressed in a broad range of solid tumours. It is expected to be ready for clinical testing ...
Inhalers for chronic obstructive pulmonary disease (COPD) are a mainstay of treatment. These medications are inhaled through your mouth so they can directly reach your lungs. If your healthcare ...